• Citer

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.

par Dieci, Maria Vittoria;Radosevic-Robin, Nina;Fineberg, Susan;Van den Eynden, Gert;Ternes, Nils;Pénault-Llorca, Frederique;Pruneri, Giancarlo;D'Alfonso, Timothy TM;Demaria, Sandra;Castaneda, Carlos;Sanchez, Joselyn;Badve, Sunil;Michiels, Stefan ;Bossuyt, Veerle Ilse Julie;Rojo, Federico;Singh, Baljit;Nielsen, Torsten;Viale, Giuseppe;Kim, Seong-Rim;Hewitt, Stephen M;Wienert, Stephan;Loibl, Sibylle;Rimm, David D.L.;Symmans, Fraser;Denkert, Carsten;Adams, Sylvia;Loi, Sherene ;Salgado, Roberto;International Immuno-Oncology Biomarker Working Group on Breast Cancer,
Référence Seminars in cancer biology, 52, Pt 2, page (16-25)
Publication Publié, 2018

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques